+13.1%
GSK vs IDXX
-2.6%
+15.8%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | IDXX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +3.9% | +1.1% | +4.4% |
| 7D | +4.9% | +24.1% | -19.2% | +1.3% |
| 30D | +9.9% | +32.5% | -22.7% | +4.2% |
| 3M | +0.2% | +18.8% | -18.6% | -2.4% |
| 6M | +2.3% | +24.0% | -21.7% | -1.6% |
| YTD | +7.1% | +3.3% | +3.8% | +6.4% |
| 1Y | +13.1% | -3.3% | +16.4% | +13.3% |
| All | +13.1% | -2.6% | +15.8% | +13.3% |
Cumulative growth
Daily Returns
Daily percentage return beside IDXX.
Daily Out/Under-Performance
Portfolio return minus IDXX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IDXX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded IDXX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling